tm logo
RESMAXVY
Live/Pending
PUBLISHED FOR OPPOSITION

on 23 Apr 2024

Last Applicant/ Owned by

GSK Medicines Research Centre

Stevenage

GB

SG12NY

Serial Number

97542578 filed on 10th Aug 2022

Registration Number

N/A

Correspondent Address

Elizabeth K. RuckiGSK

Filing Basis

1. intent to use

Disclaimer

NO DATA

RESMAXVY

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiraRead More

Classification Information


Class [005]
Pharmaceutical Products


Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Mark Details


Serial Number

No 97542578

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 84187237

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
23rd Apr 2024OICIAL GAZETTE PUBLICATION CONIRMATION E-MAILE
23rd Apr 2024PUBLISHE OR OPPOSITION
03rd Apr 2024NOTIICATION O NOTICE O PUBLICATION E-MAILE
18th Mar 2024APPROVE OR PUB - PRINCIPAL REGISTER
18th Mar 2024SUSPENSION CHECKE - TO ATTORNEY OR ACTION
15th Mar 2024TEAS/EMAIL CORRESPONENCE ENTERE
15th Mar 2024CORRESPONENCE RECEIVE IN LAW OICE
10th Jan 2024SUSPENSION CHECKE - TO ATTORNEY OR ACTION
27th Sep 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVE
12th Jul 2023TEAS CHANGE O CORRESPONENCE RECEIVE